Sara M. Onyango

FDA investigator

Appears on 9 documents from 2019 to 2026, most often at sites in Massachusetts. Most often cites design controls (21 CFR 820.30(f)).

9
Documents on file
5.7
Observations per 483
2019
First seen
2026
Most recent

What they cite most

From 51 observations

Activity by year

2019: 2, 2020: 1, 2022: 2, 2024: 2, 2026: 2

Where

Massachusetts 4 · California 2 · Indiana 1 · New York 1 · Rhode Island 1

Often inspects with

Wendy M. Stone

Is Sara M. Onyango coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Expanse Medical Inc.Jan 15, 2026 · Pleasanton, California
483 ZIIP INCJan 12, 2026 · Pleasant Hill, California
483 Mannkind CorporationOct 3, 2024 · Marlborough, Massachusetts
483 Criticare Technologies, IncMay 10, 2024 · Warwick, Rhode Island
483 Century Pharmaceuticals, IncOct 25, 2022 · Indianapolis, Indiana
483 InfuTronix LLCFeb 15, 2022 · Natick, Massachusetts
483 ConMed CorporationSep 22, 2020 · Utica, New York

About this profile

What does Sara M. Onyango inspect?

Sara M. Onyango appears on 9 documents on file covering 9 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 820.30(f) (design controls), followed by 21 CFR 820.198 and 21 CFR 820.100(a).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Sara M. Onyango is dated Jan 15, 2026.